Affiliation:
1. First Pavlov State Medical University of St. Petersburg; Almazov National Medical Research Center
Abstract
The article provides modern data on the prevalence of cardiovascular diseases and mortality in Europe and Russia. Groups of high-risk patients requiring special attention when conducting measures to reduce cardiovascular mortality are discussed: patients with hypertension, including resistant, patients with severe dyslipidemia, heart failure, and atrial fibrillation. Particular attention is paid to the problem of effective and safe treatment and reducing cardiovascular mortality in patients with atrial fibrillation and a high risk of stroke. The treatment of these patients may be most successful due to the availability of effective medications that reduce cardiovascular mortality. The article outlines the major paradigms of modern healthcare: focus on results and patient, integration of inpatient and outpatient health care units and accelerating the innovation in the diagnosis and treatment of patients with cardiovascular diseases.
Subject
Cardiology and Cardiovascular Medicine
Reference61 articles.
1. WHO Global Action Plan for the Prevention and Control of Non-communicable Diseases 2013-2020 (resolution WHA6610, 27 May 2013), http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_R10-en.pdf?ua=1.
2. Timmis A, Townsend N, Gale CP, et al. European Society of Cardiology: Cardiovascular Disease Statistics 2019. European Heart Journal. 2020;41:12-85. doi:10.1093/eurheartj/ehz859.
3. Federal State Statistics Service https://www.gks.ru/
4. Russian Statistical Yearbook 2018, p. 694. (In Russ.) https://www.world-heart-federation.org/cvd-roadmaps.
5. Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. JACC. 2017;70:1-25. doi:10.1016/j.jacc.2017.04.052.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献